Eisai Company, Ltd. (ESALY.PK) and MGI PHARMA, INC. (MOGN) Announce Early Termination of HSR Waiting Period for Eisai's Acquisition of MGI PHARMA  
1/17/2008 8:36:38 AM

TOKYO & BLOOMINGTON, Minn.--(BUSINESS WIRE)--Eisai Co., Ltd. (Tokyo, TSE: 4523) (“Eisai”) and MGI PHARMA, INC. (NASDAQ: MOGN) (“MGI PHARMA”) announced today that the Federal Trade Commission has granted early termination of the statutory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), applicable to the acquisition of MGI PHARMA by Eisai.